Table 6.
Association of tumoral BRD4 expression with IHC markers
| Marker† | BRD4/low | % | BRD4/high | % | P-value** |
|---|---|---|---|---|---|
| (n = 143)a | (n = 469)a | ||||
| Number | Number | ||||
| Her2 | |||||
| Negative | 129 | 92.8 | 414 | 93.2 | 0.8587 |
| Positive | 10 | 7.2 | 30 | 6.8 | |
| ER | |||||
| Negative | 35 | 29.2 | 109 | 28.1 | 0.8196 |
| Positive | 85 | 70.8 | 279 | 71.9 | |
| PR | |||||
| Negative | 59 | 49.6 | 167 | 42.2 | 0.1533 |
| Positive | 60 | 50.4 | 229 | 57.8 | |
| EGFR | |||||
| Negative | 117 | 96.7 | 376 | 93.3 | 0.1931 |
| Positive | 4 | 3.3 | 27 | 6.7 | |
| CK5 | |||||
| Negative | 105 | 85.4 | 341 | 80.4 | 0.2137 |
| Positive | 18 | 14.6 | 83 | 19.6 | |
| Ki67 | |||||
| < 14% | 64 | 54.7 | 144 | 37.4 | 0.0009 |
| > =14% | 53 | 45.3 | 241 | 62.6 | |
**from Chi-Square or Fisher’s exact test
aIHC marker data are not available for some tumors